These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36912952)

  • 1. Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies.
    Saracino AM; Kelberman D; Otto GW; Gagunashvili A; Abraham DJ; Denton CP
    Arch Dermatol Res; 2023 Sep; 315(7):2035-2056. PubMed ID: 36912952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways.
    Clark KEN; Gak N; Orteu CH; Ong VH; Derrett-Smith EC; Denton CP
    Clin Exp Rheumatol; 2023 Aug; 41(8):1644-1651. PubMed ID: 37223904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause profibrotic changes in linear morphoea fibroblasts.
    Badshah II; Brown S; Weibel L; Rose A; Way B; Sebire N; Inman G; Harper J; O'Shaughnessy RFL
    Br J Dermatol; 2019 May; 180(5):1135-1149. PubMed ID: 30367460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear morphoea follows Blaschko's lines.
    Weibel L; Harper JI
    Br J Dermatol; 2008 Jul; 159(1):175-81. PubMed ID: 18503590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular pathogenesis of morphoea: from genetics to future treatment targets.
    Saracino AM; Denton CP; Orteu CH
    Br J Dermatol; 2017 Jul; 177(1):34-46. PubMed ID: 27553363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, histological and high-frequency ultrasonographic evaluation (50 MHz) of morphoea treated with ultraviolet A1 phototherapy.
    Arisi M; Lorenzi L; Incardona P; Fusano M; Zanca A; Rossi MT; Tomasi C; Calzavara-Pinton PG; Venturini M
    Clin Exp Dermatol; 2019 Apr; 44(3):270-276. PubMed ID: 29974485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre.
    Saracino AM; George C; Nihtyanova SI; Denton CP
    J Scleroderma Relat Disord; 2021 Feb; 6(1):102-108. PubMed ID: 35382251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphoea with prominent plasma cell endoneuritis.
    Singh M; Farquharson N; Owen C; Howat AJ; Singh S; Francis N; Calonje E
    Clin Exp Dermatol; 2017 Mar; 42(2):196-199. PubMed ID: 28052367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of dendritic cell populations using a revised histological staging of morphoea.
    Gilmour TK; Wilkinson B; Breit SN; Kossard S
    Br J Dermatol; 2000 Dec; 143(6):1183-92. PubMed ID: 11122019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction of high-quality epidermal RNA after ammonium thiocyanate-induced dermo-epidermal separation of 4 mm human skin biopsies.
    Clemmensen A; Thomassen M; Clemmensen O; Tan Q; Kruse TA; Petersen TK; Andersen F; Andersen KE
    Exp Dermatol; 2009 Nov; 18(11):979-84. PubMed ID: 19645824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized scleroderma (morphoea): thickness of sclerotic plaques as measured by 15 MHz pulsed ultrasound.
    Serup J
    Acta Derm Venereol; 1984; 64(3):214-9. PubMed ID: 6204482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen specific amino acids in skin in localized scleroderma.
    Serup J; Ammitzbøll T; Møller R
    Acta Derm Venereol; 1984; 64(2):99-106. PubMed ID: 6203316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea.
    Fawzi MM; Tawfik SO; Eissa AM; El-Komy MH; Abdel-Halim MR; Shaker OG
    Br J Dermatol; 2008 Jul; 159(1):86-90. PubMed ID: 18489607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal thickness in systemic sclerosis and morphoea.
    Morley SM; Gaylarde PM; Sarkany I
    Clin Exp Dermatol; 1985 Jan; 10(1):51-7. PubMed ID: 3987086
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):673-678. PubMed ID: 32472964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody in localised scleroderma.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Ann Rheum Dis; 2003 Aug; 62(8):771-4. PubMed ID: 12860735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Linear scleroderma in children (apropos of 27 cases)].
    Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM
    Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients.
    Pequet MS; Holland KE; Zhao S; Drolet BA; Galbraith SS; Siegel DH; Chiu YE
    Br J Dermatol; 2014 Apr; 170(4):895-900. PubMed ID: 24341905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous morphoea: a clinical study of sixteen cases.
    Person JR; Su WP
    Br J Dermatol; 1979 Apr; 100(4):371-80. PubMed ID: 454564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized morphoea associated with oral submucous fibrosis.
    Ahmed A; Amjad M
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):141-2. PubMed ID: 16499811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.